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The on-going debates on the competitiveness of endovascular and conventional surgery in the treatment of peripheral 
occlusive vascular diseases are justified by the fact that endovascular procedures are associated with a lower mortality and 
morbidity, require a shorter hospital stay, and are less costly than conventional surgery. 
However, scientific and economic omparisons between the two techniques are difficult because they cannot strictly be 
applied to the same patients. Patients who may benefit from endovascular surgery are generally at an earlier stage of the 
disease, they have claudication and short stenoses or occlusion. On the other hank patients who present with severe 
claudication or critical ischaemia, in most cases, have long occlusions, multiple segmental disease and often require 
conventional surgery. 
The Basis for Comparison 
The basis for comparing the two techniques comes 
from randomised and non randomised studies. 
Randomised studies 
Regarding randomised studies, two groups of patients 
should be considered to answer the important ques- 
tion of the current place of endovascular surgery. In 
the first group (patients with mild symptoms and 
short lesions) endovascular procedures hould be 
compared to medical treatment, since it is not essential 
to submit them to surgery. As far as we know, such a 
study has not yet been conducted. The second group 
comprises patients with severe symptoms but rela- 
tively short lesions treatable ither by conventional 
surgery or by endovascular techniques. Wilson et al. I 
in a prospective randomised study showed 0.8% 
mortality in the surgical group v. 0% in the endovas- 
cular group. There were 7% early failures in the 
surgical group and 19% in the endovascular group. 
The complication rate was 33% in the endovascular 
group. If early failures were excluded from the study, 
the outcome at 3 years, calculated on incidence of 
study-related eaths, amputations, and late inter- 
ventions, was no different for the two treatments. 
Non-randomised studies 
Many papers have been published in the field of 
endovascular techniques. They have been written by 
different specialists involved in the endovascular 
procedures: interventional radiologists, vascular sur- 
geons, cardiologists and even internists devoted to 
vascular medicine. In the best cases these specialists 
are working together in a multidisciplinary team; in 
the worst, they may compete and the ways in which 
the results are presented may be quite different. 
Guidelines on reporting standards for endovascular 
procedures are recent 2 and only a few reports enable 
the physician to compare series and to draw precise 
conclusions. This is particularly true with the long- 
term results. 
The mortality of angioplasty is low, usually below 
1%. The rate of complications including groin haema- 
tomas, false aneurysms, and distal embolisms, ranges 
between 6% and 13%. 3,4 Early and late failures have to 
be analysed separately since mechanisms are different. 
Most early failures are due to failure to cross the lesion 
or inadequate dilatation. This is most frequent with 
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totally occluded arteries, or eccentric, heavy calcified 
stenoses. Optimal selection of patients and technical 
skills may improve the success rate. Late failures are 
due to restenosis or reocclusion, at the site or close to 
the site of the angioplasty. Factors which affect late 
failure following a successful angioplasty have been 
identified. Some are identical to those factors which 
increase the risk of failure of bypass grafts: they 
include pre-operative symptoms (critical ischaemia v. 
claudication), site of the angioplasty (small arteries v. 
large arteries) and run-off. 4-6 Others are specific to 
angioplasty: occlusion v. stenosis and the length of the 
5--7 lesion. It is difficult to know precisely the critical 
length of the lesion for which angioplasty will 
certainly fail it is probably around 5 cm in length. This 
is due to the different ypes of occlusion, which can 
consist of extensive atheroma, or fresh thrombus 
surrounding a short stenosis. 
At the iliac level Johnston 7observed an immediate 
success rate of 96.5%. For occluded arteries the I year 
patency rate was 59.8%, and 48% at 3 years. For 
stenotic arteries, the patency rate was 77.2% at I year, 
61% at 3 years, and 54% at 5 years. The long-term 
patency following angioplasty was better for the 
common iliac artery than for the external iliac artery. 
At the femoral evel Becker analysed 28 series in the 
literature, s The immediate success rate was 81%. At 2 
years the success rate ranged from 43%-79%. In our 
own experience, 6 the patency was 78% for stenosis 
and 20% for occlusion. It was 80% for lesions shorter 
than 2 cm, 40% for lesions between 2 cm and 8 cm and 
0% for lesions exceeding 8 cm. 
Restenosis or reocclusion does not always lead to 
the recurrence of symptoms. In our series,O one third 
of patients with reocclusion following a successful 
angioplasty of the superficial femoral artery, never- 
theless improved their walking distance. 
Technological Developments 
The technology of endovascular therapy is rapidly 
evolving in the quest for improving early success, and 
reducing restenosis. This evolution includes the 
guides and catheters (glideness, flexibility, smooth- 
ness, diameter, steerability), the balloons (size, profile, 
resistance, compliance), the stents (expandability, 
rigidity, stent-graft). Devices aimed at opening 
occluded or severely stenosed arteries (rotablator, 
different types of lasers, intra-arterial delivery of 
drugs systems), and more recently destruction of 
plaque with ultrasound may also be of use in selected 
cases. The numerous methods of assessment, such as 
digital imaging, angioscopy, intravascular ultrasound, 
and 3-D reconstruction add to the hope of improving 
the results given by the plain old balloon. 
However, it is not obvious that these new devices 
improve the results. In a randomised study, 9 the 
results from laser-assisted angioplasty were poorer 
than angioplasty alone. Rotablator, as well as Simpson 
catheters are not superior to balloons alone. Stents are 
probably more interesting. Palmaz et al. 1° have shown 
that stenting may increase long-term patency after 
iliac angioplasty. However, iliac stents are probably 
not useful for all angioplasties and stents should be 
applied only in selected cases such as an occluded 
artery, dissection, or persistent stenosis following 
angioplasty. At the femoral evel the results of stents 
are disappointing and if there is a subgroup of 
patients who may benefit from stenting, it has not yet 
been identified. 
Surgical Advances 
Conventional surgery has its own advantages and 
drawbacks and is associated with different rates of 
mortality/morbidity and patency depending on the 
type of procedure. Pooling the results of these very 
different operations and establishing a comparison 
with angioplasty give only a schematic idea of the 
problem. 
In recent series, the mortality of aorto iliac recon- 
struction for occlusive disease ranged from 1.6% for 
Darling et al, 11 2% in our own experience, 12and 2.5% 
for Szilagyi et al. 13 The 5 year patency rate was 74% in 
our series, 76.6% in those of Szilagyi et al. and 82% in 
those of Darling et al. At the infra-inguinal level, the 
mortality rate ranged from 3%-12% (4% in our own 
series). Long-term patency of femoro-popliteal recon- 
struction, depends mainly on the availability of the 
greater saphenous vein. Dalman and Taylor 14 in an 
analysis of the literature, found that for above the knee 
revascl~larisation the patency ranged from 60%-70% 
at 4 years. For below the knee revascularisations the 
4-year patency varied from 70% for venous grafts to 
40% for PTFE grafts. 
Complications which may supervene in the long- 
term include false aneurysms, thrombosis, deteriora- 
tion of grafts, and sepsis. Some of these complications 
may still be lethal despite the progress in early 
recognition and treatment. Other complications of 
vascular surgery should be kept in mind such as small 
bowel obstruction following laparotomy, or impotence 
following aortic surgery. 
With the lack of new concepts in the field of 
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conventional surgery, refinement in techniques, care- 
ful preoperative screening and selection of patients, 
progress in anaesthesia, nd adjuvant herapy may 
increase the success rate of conventional surgery but 
only slightly. 
of success is high, then endovascular surgery should 
be chosen first. When the probability is low, in patients 
with good surgical risk we favour conventional 
surgery. In patients with poor surgical risk, an 
endovascular ttempt may be worthwhile. 
Comparative Costs 
At first sight, balloon angioplasty appears less costly 
than surger~ especially with a reduced hospitalisation 
time. But the comparison must take into account he 
extra cost of the new devices available on the market 
which are more expensive than the plain balloon: the 
use of more than one guide and balloon for difficult 
procedures, the placement of one or several stents, 
and when a complication occurs, the use of thrombo- 
lyric therapy and the need for procedures to be 
repeated, including surgery whenever the procedure 
fails. The lower cost of angioplasty must be balanced 
by the exponential increase of the procedures. Tunis et 
al. 15 have shown that the number of angioplasties per 
100000 inhabitants has increased 24-fold between 
1979 and 1994 in the state of Maryland, wi th no 
reduction in conventional surgery and amputation. 
This leads to the question of the over-utilisarion of 
balloon angioplasty especially in patients with mild 
symptoms or in patients where unsuccessful attempts 
have been made. 
In Summary, except for a few patients, endovascular 
surgery and conventional surgery are not competitive 
since they are directed towards different ypes of 
lesions. Endovascular surgery presents a lower mor- 
tality related procedure rate than conventional sur- 
gery but a higher failure rate. However, failure of 
endovascular surgery can be treated by a repeat 
endovascular p ocedure or by conventional surgery. 
With our current knowledge how can we choose 
between the two techniques? In our opinion, the 
choice should be made according to the probability of 
success with endovascular surgery. If the probability 
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